BR
BioRegenx, Inc.
BRGX · OTC
$0.01 +8.33% (+$0.00)
1M +0.00%
Market Cap $6.32M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Moderate
5/9Valuation
14 /100
Expensive P/S 3.58x
P/FCF 335.03x
P/E N/A
Growth
100 /100
Growing Rev. growth 253.00%
EPS growth N/A
Book val. growth N/A
Profitability
24 /100
Weak Gross margin 81.90%
FCF margin 1.07%
Net margin 73.80%
Quality
79 /100
Excellent ROIC 22.55%
Asset turnover 5.24x
ROA 386.56%
Debt
0 /100
High Current ratio 0.05x
Int. coverage -1.24x
Debt/Equity N/A
Stability
13 /100
Unstable Beta -2.71x
Profitable years 0
Rev. volatility 6,035.73%
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o BRGX
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
William Resides
Employees
6
Headquarters
Chattanooga